Taiho and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor Read more
Moderna Announces Dosing of the First Monoclonal Antibody Encoded by mRNA in a Clinical Trial Read more
FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897 Read more
Isatuximab Phase 3 trial meets primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma Read more
Trevi Announces License Agreements for use of Nalbuphine for the Treatment of LID in Parkinson’s Disease Read more